Latest News by Industry
NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Thursday reported a loss of $26.8 million in its third quarter.
On a per-share basis, the North Carolina, North Carolina-based company said it had a loss of 56 cents. Losses, adjusted for non-recurring costs, came to 27 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
The drugmaker posted revenue of $36.1 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $35.1 million.
Aerie shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $15.23, a climb of 28% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a AERI">Zacks stock report on AERI at https://www.zacks.com/ap/AERI